RepliCel Life Sciences : CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS - Form 6-K

CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS





For the three months ended March 31, 2023 and 2022





Notice of No Auditor... | May 31, 2023

Related Keywords

Macau ,Taiwan ,Canada ,China ,United States ,Hong Kong ,Vancouver ,British Columbia ,Chinese ,Canadian ,Lee Buckler ,David Hall ,While The Company ,Mainpointe Pharmaceuticals ,Technology Transfer Agreement ,Given The Company ,Company Stock Option Plan ,Company Or Replicel ,International Accounting Standards Board ,Share Of The Company ,Replicel Life Sciences Inc ,Venture Exchange The ,Venture Exchange ,Party Transactions ,Shiseido Company ,Bus Partnership ,International Financial Reporting Standards ,Company Options ,China Health Industry Co ,National Instrument ,Trichoscience Innovations Inc ,Canadian Dollars ,Interim Financial ,Consolidated Interim Statements ,Cel Life Sciences ,Ontario Business Corporations Act ,Replicel Life Sciences ,Trichoscience Innovations ,Accounting Estimates ,Collaboration Agreement ,Health Industry ,Life Sciences ,Replicel Injector Product Line ,Collaborative Agreement ,Greater China ,Mainland China ,Contract Liability ,License Fee ,Share Purchase Agreement ,Distribution Agreement ,Cel Injector Product ,Royalty Participation Agreement ,Chief Technology Officer ,Discounted Market Price ,Aging Skin ,Chronic Tendinosis ,Treatment Androgenic Alopecia ,Replicel Injector Product ,Payback Period ,Issue Date ,Required Redemption Date ,Redemption Price ,Novel Coronavirus ,Canada Emergency Business Account ,Government Grants ,Government Assistance ,Government Grant ,News Release ,Preferred Shares ,Each Warrant ,Stock Option Plans ,Stock Option Plan ,Company Options Issued ,Founders Stock Option Agreements ,Chief Executive Officer ,Chief Financial ,Shiseido Company Limited ,Granted Options ,Rolling Stock Option ,Each Option ,Replicel Life Sciences Inc Stock Exchange ,News ,Information ,Press Release ,Ondensed ,Onsolidated ,Interim ,Financial ,Or ,The ,Three ,Months ,Nded ,Arch ,023 ,End ,Notice ,F ,O Repcf Ca76027p4006 ,